US Drug Recall Register
Class III · Low risk Terminated Initiated Jun 12, 2023 (3 years ago)

Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

What was recalled

Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30

Recalling firm
Amring Pharmaceuticals Inc
NDC code
69918-301-30
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0871-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tranexamic recalls

See all